Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126014301 | 12601430 | 1 | I | 20160620 | 20160720 | 20160728 | 20160728 | EXP | US-ROCHE-1799565 | ROCHE | 56.95 | YR | F | Y | 60.00000 | KG | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126014301 | 12601430 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | DAY 1 + 15, 25/MAY/2016 LAST DOSE PRIOR TO EVENT | 1150135 | 125085 | 10 | MG/KG | |||||||
| 126014301 | 12601430 | 2 | SS | CAPECITABINE. | CAPECITABINE | 1 | Oral | DAY 1-14, 25/MAY/2016 LAST DOSE PRIOR TO EVENT | X3720X1 | 20896 | 750 | MG/M**2 | TABLET | BID | |||||
| 126014301 | 12601430 | 3 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Oral | DAY 10-14, EVERY BEDTIME (QHS- QUAQUE HORA SOMNI)?25/MAY/2016 LAST DOSE PRIOR TO EVENT | L032415 | 0 | 200 | MG/M**2 | QD | ||||||
| 126014301 | 12601430 | 4 | SS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Intravenous (not otherwise specified) | L032415 | 0 | ||||||||||
| 126014301 | 12601430 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | |||||||||||
| 126014301 | 12601430 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | |||||||||||
| 126014301 | 12601430 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | TABLET | ||||||||||
| 126014301 | 12601430 | 8 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | 50-12.5 MG | 0 | TABLET | |||||||||
| 126014301 | 12601430 | 9 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | 0 | |||||||||||
| 126014301 | 12601430 | 10 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 0 | TABLET | TID | |||||||||
| 126014301 | 12601430 | 11 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | CAPSULE | QD | |||||||||
| 126014301 | 12601430 | 12 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | CAPSULE | ||||||||||
| 126014301 | 12601430 | 13 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | 1 TAB 30-60MIN BEFORE TEMOZOLOMIDE | 0 | TABLET | |||||||||
| 126014301 | 12601430 | 14 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 4 | MG | Q8H | ||||||||
| 126014301 | 12601430 | 15 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 0 | TABLET | Q8H | |||||||||
| 126014301 | 12601430 | 16 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 0 | |||||||||||
| 126014301 | 12601430 | 17 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 126014301 | 12601430 | 18 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126014301 | 12601430 | 1 | Pancreatic neuroendocrine tumour metastatic |
| 126014301 | 12601430 | 2 | Pancreatic neuroendocrine tumour metastatic |
| 126014301 | 12601430 | 3 | Pancreatic neuroendocrine tumour metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126014301 | 12601430 | OT |
| 126014301 | 12601430 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126014301 | 12601430 | Abdominal pain | |
| 126014301 | 12601430 | Duodenal ulcer | |
| 126014301 | 12601430 | Haematemesis | |
| 126014301 | 12601430 | Nausea | |
| 126014301 | 12601430 | Small intestinal haemorrhage | |
| 126014301 | 12601430 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126014301 | 12601430 | 1 | 20160316 | 0 | ||
| 126014301 | 12601430 | 2 | 20160316 | 0 | ||
| 126014301 | 12601430 | 3 | 20160316 | 0 | ||
| 126014301 | 12601430 | 4 | 20160707 | 20160711 | 0 | |
| 126014301 | 12601430 | 5 | 20160614 | 0 | ||
| 126014301 | 12601430 | 6 | 20160620 | 20160621 | 0 | |
| 126014301 | 12601430 | 7 | 20160707 | 20160712 | 0 | |
| 126014301 | 12601430 | 8 | 20160104 | 0 | ||
| 126014301 | 12601430 | 10 | 20160105 | 0 | ||
| 126014301 | 12601430 | 11 | 20160110 | 0 | ||
| 126014301 | 12601430 | 12 | 20160620 | 20160620 | 0 | |
| 126014301 | 12601430 | 13 | 20160316 | 0 | ||
| 126014301 | 12601430 | 14 | 20160620 | 20160621 | 0 | |
| 126014301 | 12601430 | 15 | 20160707 | 20160707 | 0 |